Entropy Technologies LP Decreases Stake in The Clorox Company (NYSE:CLX)

Entropy Technologies LP cut its position in The Clorox Company (NYSE:CLX) by 35.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,825 shares of the company’s stock after selling 3,767 shares during the period. Entropy Technologies LP’s holdings in Clorox were worth $1,112,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of CLX. Mizuho Markets Americas LLC increased its holdings in Clorox by 93.7% in the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after buying an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in shares of Clorox by 15.2% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after acquiring an additional 18,687 shares during the last quarter. Advisors Asset Management Inc. raised its position in shares of Clorox by 257.5% during the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after acquiring an additional 8,087 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new stake in Clorox during the third quarter worth approximately $54,000. Finally, Raymond James & Associates boosted its holdings in Clorox by 32.8% in the second quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock valued at $36,524,000 after purchasing an additional 66,149 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CLX shares. DA Davidson boosted their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Evercore ISI dropped their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Citigroup lifted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, Barclays increased their price objective on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $155.00.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.57% of the stock is owned by insiders.

Clorox Price Performance

Shares of CLX opened at $165.37 on Thursday. The firm has a market capitalization of $20.47 billion, a PE ratio of 57.62, a P/E/G ratio of 3.04 and a beta of 0.41. The stock’s 50 day moving average is $162.35 and its two-hundred day moving average is $147.08. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $169.09. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the company posted $0.49 earnings per share. Clorox’s quarterly revenue was up 27.0% on a year-over-year basis. Research analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were issued a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. Clorox’s dividend payout ratio is presently 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.